DECAGLIM-M2
Glimepiride 2 mg + Metformin Hydrochloride ER 500 mg
DECAGLIM-M2
DECAGON PHARMACEUTICALS
- Dosage Form
- Tablets
- Packaging
- 10 x 15 Tablets
Overview of DECAGLIM-M2
DECAGLIM-M2 Tablets combine Glimepiride (2 mg) and Metformin Hydrochloride Extended Release (500 mg). Designed for patients requiring higher insulin secretagogue potency to achieve robust glycemic control and prevent diabetic complications.
Indicated for Type 2 Diabetes inadequately controlled on lower-dose dual therapy or monotherapy, hyperinsulinemia, and long-term vascular protection.
"DECAGLIM-M2 — Manage Proper Glucose Level for Well-Being."
Clinical Evidence Context: Indications: Type 2 Diabetes Mellitus, Hyperinsulinemia, and Prevention of Macrovascular & Microvascular Complications.
Diabetic Care
Tablets
More in Diabetic Care
View categoryDECAGLIM-M1
Glimepiride 1 mg + Metformin Hydrochloride ER 500 mg
DECAGLIM-MV1
Glimepiride 1 mg + Metformin 500 mg ER + Voglibose 0.2 mg
DECAGLIM-MV2
Glimepiride 2 mg + Metformin 500 mg ER + Voglibose 0.2 mg